Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Vitamin D Deficiency 1Motor Activity 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Cisplatin 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Completed × Vitamins × Clear all
NCT03644212 2020-01-13

Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS

Maimonides Medical Center

Phase 4 Completed
79 enrolled 5 charts

Polycystic Ovary Syndrome, Vitamin D Deficiency

NCT00593294 2008-01-15

Oral Contraceptive and Cardiovascular Risk in PCOS

Federico II University

Phase 4 Completed
150 enrolled

Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡